Diagnosing human cutaneous leishmaniasis using fluorescence in situ hybridization
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
PATHOGENS AND GLOBAL HEALTH
Abstract
Cutaneous leishmaniasis (CL) is endemic in Sri Lanka. Giemsa-stained slit-skin-smears (SSSGiemsa) and histology are routinely used in diagnosis with a sensitivity of 40–70%. PCR
currently has limited accessibility. Therefore, we assessed the sensitivity and specificity of a
previously described fluorescence in situ hybridization assay, on skin smears and biopsy
samples to overcome the limitations encountered with routine diagnostic methods.
Samples from a total of 123 suspected CL patients were collected and subjected to SSSGiemsa, fluorescence in situ hybridization (FISH) on slit skin smears (SSS-FISH), formalin-fixedparaffin-embedded-tissues stained with Hematoxylin & Eosin staining (FFPE-H&E) and FISH on
formalin-fixed-paraffin-embedded-tissues (FFPE-FISH). Negative controls of 61 patient samples
were collected from a CL non-endemic area and subjected to the same procedures. The gold
standard PCR was used as a comparator. For FISH, two previously described cyanine 3 tagged
Leihsmania genus-specific probes were used.
Compared to PCR, SSS-Giemsa, SSS-FISH, FFPE-H&E, and FFPE-FISH had sensitivities of 76.5%,
79.1%, 50.4% and 80.9%, respectively. Routine diagnostic tests (SSS-Giemsa and FFPE-H&E) had
a specificity of 100%. SSS-FISH and FFPE-FISH had specificities of 96.7% and 93.4%, respectively.
FFPE-FISH had a statistically significant higher diagnostic performance than FFPE-H&E
(p < 0.001). The relative performance of SSS-Giemsa, SSS-FISH and FFPE-FISH was similar
(p > 0.05 for all comparisons).
We conclude that FFPE-FISH is a more accurate diagnostic tool than FFPE–H&E. SSS-FISH did
not have an additional advantage over SSS-Giemsa in diagnosis. However, SSS-FISH could be
recommended as a minimally invasive method in studies assessing wound healing where
immunological probes are used.
Description
Citation
Kaluarachchi, T. J., et al. (2021). Diagnosing human cutaneous leishmaniasis using fluorescence in situ hybridization. PATHOGENS AND GLOBAL HEALTH, 22021.
